相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。SCH527123, a novel CXCR2 antagonist, inhibits ozone-induced neutrophilia in healthy subjects
O. Holz et al.
EUROPEAN RESPIRATORY JOURNAL (2010)
被撤回的出版物: CXCR2 mediates NADPH oxidase-independent neutrophil extracellular trap formation in cystic fibrosis airway inflammation (Retracted article. See vol. 17, pg. 899, 2011)
Veronica Marcos et al.
NATURE MEDICINE (2010)
Evidence that cathelicidin peptide LL-37 may act as a functional ligand for CXCR2 on human neutrophils
Zhifang Zhang et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2009)
The functional significance behind expressing two IL-8 receptor types on PMN
RoseMarie Stillie et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2009)
CXCR2 antagonists for the treatment of pulmonary disease
R. W. Chapman et al.
PHARMACOLOGY & THERAPEUTICS (2009)
Fluticasone propionate protects against ozone-induced airway inflammation and modified immune cell activation markers in healthy volunteers
Neil E. Alexis et al.
ENVIRONMENTAL HEALTH PERSPECTIVES (2008)
Characterisation of the range of neutrophil stimulating mediators in cystic fibrosis sputum
K. J. Mackerness et al.
THORAX (2008)
Cleavage of CXCR1 on neutrophils disables bacterial killing in cystic fibrosis lung disease
Dominik Hartl et al.
NATURE MEDICINE (2007)
The neutrophil in chronic obstructive pulmonary disease
Jennifer Kathleen Quint et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2007)
A novel flow cytometric assay of human whole blood neutrophil and monocyte CD11b levels: Upregulation by chemokines is related to receptor expression, comparison with neutrophil shape change, and effects of a chemokine receptor (CXCR2) antagonist
Grant C. Nicholson et al.
PULMONARY PHARMACOLOGY & THERAPEUTICS (2007)
Discovery of 2-hydroxy-N,N-dimethyl-3-{2-[[(R)-1-(5-methylfuran-2-yl)propyl]amino]-3,4-dioxocyclobut-1-enylamino}benzamide (SCH 527123):: A potent, orally bioavailable CXCR2/CXCR1 receptor antagonist
Michael P. Dwyer et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Neutrophilic inflammation as a major determinant in the progression of cystic fibrosis
Rabindra Tirouvanziam
DRUG NEWS & PERSPECTIVES (2006)
A novel peptide CXCR ligand derived from extracellular matrix degradation during airway inflammation
NM Weathington et al.
NATURE MEDICINE (2006)
Small molecule antagonists of the CXCR2 and CXCR1 chemokine receptors as therapeutic agents for the treatment of inflammatory diseases
Jakob Busch-Petersen
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2006)
Validation of the human ozone challenge model as a tool for assessing anti-inflammatory drugs in early development
O Holz et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2005)
Neutrophils in innate immunity
Q Wang et al.
SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE (2004)
Contrasting roles for CXCR2 during experimental colitis
MN Ajuebor et al.
EXPERIMENTAL AND MOLECULAR PATHOLOGY (2004)
Macrophage phagocytosis of apoptotic neutrophils is compromised by matrix proteins modified by cigarette smoke and lipid peroxidation products
PA Kirkham et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
The chemokine receptor CXCR2 controls positioning of oligodendrocyte precursors in developing spinal cord by arresting their migration
HH Tsai et al.
CELL (2002)
Budesonide reduces neutrophilic but not functional airway response to ozone in mild asthmatics
B Vagaggini et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2001)
Identification and characterization of a potent, selective, and orally active antagonist of the CC chemokine receptor-1
M Liang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Impaired immunity and enhanced resistance to endotoxin in the absence of neutrophil elastase and cathepsin G
J Tkalcevic et al.
IMMUNITY (2000)
分享论文
